O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 131.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+131.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.17B
AUM Growth
+$193M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$52.4M
2
+$48.2M
3
+$38.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$29.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$28.9M

Top Sells

1
+$105M
2
+$93.6M
3
+$81.8M
4
BSX icon
Boston Scientific
BSX
+$39.8M
5
CYTK icon
Cytokinetics
CYTK
+$35.6M

Sector Composition

1 Healthcare 99.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-700,000
102
– –
0
103
– –
0
104
– –
0
105
– –
-465,000
106
– –
-804,603
107
– –
-557,900
108
– –
-3,344,568
109
– –
0
110
– –
-416,900
111
– –
-1,077,000
112
– –
-677,977
113
– –
-336,300
114
– –
-210,287
115
– –
-231,000
116
– –
-54,799
117
– –
-5,779,071
118
– –
-3,099,265
1 2 3 4
5